Tenecteplase Prior to Mechanical Thrombectomy: Ready for Prime Time?

Neurology. 2021 Mar 2;96(9):413-414. doi: 10.1212/WNL.0000000000011519. Epub 2021 Jan 6.

Authors

Michelle P Lin¹, Kameshwar Prasad²

Affiliations

¹ From the Department of Neurology (M.P.L.), Mayo Clinic, Jacksonville, FL; All India Institute of Medical Sciences (K.P.), New Delhi; and Rajendra Institute of Medical Sciences (K.P.), Ranchi, India. lin.michelle@mayo.edu.
² From the Department of Neurology (M.P.L.), Mayo Clinic, Jacksonville, FL; All India Institute of Medical Sciences (K.P.), New Delhi; and Rajendra Institute of Medical Sciences (K.P.), Ranchi, India.

PMID: 33408140
DOI: 10.1212/WNL.0000000000011519

No abstract available

Publication types

Editorial
Research Support, N.I.H., Extramural
Comment

MeSH terms

Basilar Artery
Endovascular Procedures*
Fibrinolytic Agents / therapeutic use
Humans
Tenecteplase
Thrombectomy
Tissue Plasminogen Activator* / therapeutic use

Substances

Fibrinolytic Agents
Tissue Plasminogen Activator
Tenecteplase

Grants and funding

KL2 TR002379/TR/NCATS NIH HHS/United States